Eyes could reveal hidden clues about MS treatment success

NCT ID NCT06733922

Recruiting now Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing a new eye-tracking tool to see if it can detect subtle changes in eye movements that might indicate how well a multiple sclerosis (MS) treatment is working. It will involve 224 Canadian adults with active relapsing-remitting MS who are already prescribed the medication ofatumumab. The main goal is to see if these eye movement measurements can provide useful information alongside standard MS tests over two years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Novartis Investigative Site
RECRUITING

Calgary, Alberta, T2N 4N1, Canada
Novartis Investigative Site
RECRUITING

Calgary, Alberta, T3M 1M4, Canada
Novartis Investigative Site
RECRUITING

Edmonton, Alberta, T6G 2C8, Canada
Novartis Investigative Site
RECRUITING

Burnaby, British Columbia, V5G 2X6, Canada
Novartis Investigative Site
RECRUITING

Vancouver, British Columbia, V6T 2A1, Canada
Novartis Investigative Site
RECRUITING

St. John's, Newfoundland and Labrador, A1B 3V6, Canada
Novartis Investigative Site
RECRUITING

Halifax, Nova Scotia, B3H 3A7, Canada
Novartis Investigative Site
RECRUITING

Halifax, Nova Scotia, B3R 1V9, Canada
Novartis Investigative Site
RECRUITING

Ottawa, Ontario, K1H 8L6, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H1K 3V9, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H3A 0G4, Canada
Novartis Investigative Site
RECRUITING

Montreal, Quebec, H4A 3T2, Canada
Novartis Investigative Site
RECRUITING

Québec, Quebec, G1W 4R4, Canada
Novartis Investigative Site
RECRUITING

Sherbrooke, Quebec, J1G 2E8, Canada

Conditions

Explore the condition pages connected to this study.

RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS)